p53tumour-suppressor gene in non-small-cell lung cancer with neoadjuvant therapy
✍ Scribed by K. Junker; T. Wiethege; K.-M. Müller; M. Thomas
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 184 KB
- Volume
- 126
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
It has been reported that genes regulating apoptosis may play a role in tumoral angiogenesis. This study examined the relationship between tumour vascularization, a measure of tumour angiogenesis, and bcl-2 and p53 expression in operable non-small-cell lung cancer (NSCLC). The relationship between b
## Abstract The serine protease family member __PRSS3__ (__trypsinogen‐IV__) has been implicated as a putative tumor suppressor gene due to its loss of expression, which is correlated with promoter hypermethylation, in esophageal squamous cell carcinoma and gastric adenocarcinoma. As epigenetic alt